Literature DB >> 28895950

Diabetes: Cardiovascular benefits of metformin in T1DM.

Janet K Snell-Bergeon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28895950     DOI： 10.1038/nrendo.2017.116

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials.

Authors:  Sanjay Kaul
Journal:  Diabetes Care       Date:  2017-07       Impact factor: 19.112

2.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

Authors:  Aidin Rawshani; Araz Rawshani; Stefan Franzén; Björn Eliasson; Ann-Marie Svensson; Mervete Miftaraj; Darren K McGuire; Naveed Sattar; Annika Rosengren; Soffia Gudbjörnsdottir
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

Review 3.  Standards of Medical Care in Diabetes-2017: Summary of Revisions.

Authors: 
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

4.  Natural course of insulin resistance in type I diabetes.

Authors:  H Yki-Järvinen; V A Koivisto
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

5.  Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.

Authors:  Kristen J Nadeau; Judith G Regensteiner; Timothy A Bauer; Mark S Brown; Jennifer L Dorosz; Amber Hull; Phil Zeitler; Boris Draznin; Jane E B Reusch
Journal:  J Clin Endocrinol Metab       Date:  2009-11-13       Impact factor: 5.958

6.  Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.

Authors:  John R Petrie; Nishi Chaturvedi; Ian Ford; Martijn C G J Brouwers; Nicola Greenlaw; Therese Tillin; Irene Hramiak; Alun D Hughes; Alicia J Jenkins; Barbara E K Klein; Ronald Klein; Teik C Ooi; Peter Rossing; Coen D A Stehouwer; Naveed Sattar; Helen M Colhoun
Journal:  Lancet Diabetes Endocrinol       Date:  2017-06-11       Impact factor: 32.069

7.  Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.

Authors:  Shona J Livingstone; Daniel Levin; Helen C Looker; Robert S Lindsay; Sarah H Wild; Nicola Joss; Graham Leese; Peter Leslie; Rory J McCrimmon; Wendy Metcalfe; John A McKnight; Andrew D Morris; Donald W M Pearson; John R Petrie; Sam Philip; Naveed A Sattar; Jamie P Traynor; Helen M Colhoun
Journal:  JAMA       Date:  2015-01-06       Impact factor: 56.272

8.  Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.

Authors:  Shona J Livingstone; Helen C Looker; Eleanor J Hothersall; Sarah H Wild; Robert S Lindsay; John Chalmers; Stephen Cleland; Graham P Leese; John McKnight; Andrew D Morris; Donald W M Pearson; Norman R Peden; John R Petrie; Sam Philip; Naveed Sattar; Frank Sullivan; Helen M Colhoun
Journal:  PLoS Med       Date:  2012-10-02       Impact factor: 11.069

9.  Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.

Authors:  Irene E Schauer; Janet K Snell-Bergeon; Bryan C Bergman; David M Maahs; Adam Kretowski; Robert H Eckel; Marian Rewers
Journal:  Diabetes       Date:  2010-10-26       Impact factor: 9.461

10.  Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Authors:  John M Lachin; Trevor J Orchard; David M Nathan
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.